PCOS reclassification to PMOS hopes to improve diagnosis, treatment options and funding (opens in new tab)

After 14 years of global collaboration, researchers, doctors and the broader medical community reached a consensus to reclassify polycystic ovary syndrome — a disease affecting one in eight women. In a study published May 12, the disorder was renamed polyendocrine metabolic ovarian syndrome, reflecting a more comprehensive understanding of the diseases’ complex hormonal and metabolic […] The post appeared first on .